567 results on '"Lodola, Alessio"'
Search Results
102. Drug-gut microbiota metabolic interactions: the case of UniPR1331, selective antagonist of the Eph-ephrin system, in mice
103. New classes of potent heparanase inhibitors from ligand-based virtual screening
104. Benzisothiazolinone Derivatives as Potent Allosteric Monoacylglycerol Lipase Inhibitors That Functionally Mimic Sulfenylation of Regulatory Cysteines
105. Fibroblast growth factor receptor inhibitors: patent review (2015–2019)
106. Targeting the Eph/Ephrin System as Anti-Inflammatory Strategy in IBD
107. Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines
108. Mechanism of inhibition of SARS-CoV-2 Mpro by N3 peptidyl Michael acceptor explained by QM/MM simulations and design of new derivatives with tunable chemical reactivity.
109. Identification of Bivalent Ligands with Melatonin Receptor Agonist and Fatty Acid Amide Hydrolase (FAAH) Inhibitory Activity That Exhibit Ocular Hypotensive Effect in the Rabbit
110. Theoretical Model of EphA2-Ephrin A1 Inhibition
111. UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice
112. Tetrahydroquinoline Ring as a Versatile Bioisostere of Tetralin for Melatonin Receptor Ligands
113. Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype
114. Editorial: Antitarget Therapies: New Frontiers in the Treatment of Cancer
115. Mechanistic Insights into the Reaction of Chlorination of Tryptophan Catalyzed by Tryptophan 7-Halogenase
116. N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factors
117. Atropisomerism and Conformational Equilibria: Impact on PI3Kδ Inhibition of 2-((6-Amino-9H-purin-9-yl)methyl)-5-methyl-3-(o-tolyl)quinazolin-4(3H)-one (IC87114) and Its Conformationally Restricted Analogs
118. Mechanistic insights into the reaction of chlorination of tryptophan catalyzed by tryptophan 7-halogenase
119. Chapter Seven - Insights in the Mechanism of Action and Inhibition of N-Acylethanolamine Acid Amidase by Means of Computational Methods
120. EPHRIN A2 ANTAGONISM REDUCES SURVIVAL OF PROSTATE CANCR CELLS AFTER CHEMOTHERAPIC TREATMENTS AND ANGIOGENESIS IN PROSTATE CANCER CELLS BOTH IN VITRO AND IN VIVO
121. Potential Therapeutic Value of a Novel FAAH Inhibitor for the Treatment of Anxiety
122. Correction to Metadynamics Simulations Distinguish Short- and Long-Residence-Time Inhibitors of Cyclin-Dependent Kinase 8
123. Metadynamics Simulations Distinguish Short- and Long-Residence-Time Inhibitors of Cyclin-Dependent Kinase 8
124. Metadynamics for Perspective Drug Design: Computationally Driven Synthesis of New Protein–Protein Interaction Inhibitors Targeting the EphA2 Receptor
125. Long-lasting inhibition of EGFR autophosphorylation in A549 tumor cells by intracellular accumulation of non-covalent inhibitors
126. Conformational Effects on the pro-S Hydrogen Abstraction Reaction in Cyclooxygenase-1: An Integrated QM/MM and MD Study
127. Exploiting Free-Energy Minima to Design Novel EphA2 Protein-Protein Antagonists: From Simulation to Experiment and Return
128. Chapter 11 - The Increasing Role of QM/MM in Drug Discovery
129. Synthesis and Structure−Activity Relationships of N-(2-Oxo-3-oxetanyl)amides as N-Acylethanolamine-hydrolyzing Acid Amidase Inhibitors
130. Editorial (Thematic Issue: Antitarget Therapies: New Frontiers in the Treatment of Cancer)
131. Editorial (Thematic Issue: Small Molecules and Peptides Targeting the Eph-Ephrin System)
132. Targeting the Eph-ephrin System with Protein-Protein Interaction (PPI) Inhibitors
133. Fatty acid amide hydrolase inhibitors: a patent review (2009 – 2014)
134. Comparative Analysis of Virtual Screening Approaches in the Search for Novel EphA2 Receptor Antagonists
135. Highly Potent and Selective MT2 Melatonin Receptor Full Agonists from Conformational Analysis of 1-Benzyl-2-acylaminomethyl-tetrahydroquinolines
136. Amino Acid Derivatives as Palmitoylethanolamide Prodrugs: Synthesis, In Vitro Metabolism and In Vivo Plasma Profile in Rats
137. Back Cover: Pushing the Boundaries of Vinylogous Reactivity: Catalytic Enantioselective Mukaiyama Aldol Reactions of Highly Unsaturated 2‐Silyloxyindoles (Chem. Eur. J. 17/2015)
138. Pushing the Boundaries of Vinylogous Reactivity: Catalytic Enantioselective Mukaiyama Aldol Reactions of Highly Unsaturated 2-Silyloxyindoles
139. Chapter 1 - Application of Computational Methods to the Design of Fatty Acid Amide Hydrolase (FAAH) Inhibitors Based on a Carbamic Template Structure
140. Synthesis and QSAR of Fatty Acid Amide Hydrolase Inhibitors: Modulation at the N-Portion of Biphenyl-3-yl Alkylcarbamates
141. <italic>N</italic>-<italic>tert</italic>-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factors.
142. Targeting Eph/ephrin system in cancer therapy.
143. Quantum Mechanics/Molecular Mechanics Modeling of Covalent Addition between EGFR–Cysteine 797 and N-(4-Anilinoquinazolin-6-yl) Acrylamide
144. Physical Nature of Fatty Acid Amide Hydrolase Interactions with Its Inhibitors: Testing a Simple Nonempirical Scoring Model
145. Are We Using the Right Pharmacological Tools to Target EphA4?
146. Combining Ligand- and Structure-Based Approaches for the Discovery of New Inhibitors of the EPHA2–ephrin-A1 Interaction
147. Synthesis and Characterization of New Bivalent Agents as Melatonin- and Histamine H3-Ligands
148. Biphenyl-3-yl alkylcarbamates as fatty acid amide hydrolase (FAAH) inhibitors: steric effects of N-alkyl chain on rat plasma and liver stability.
149. A catalytically silent FAAH-1 variant drives anandamide transport in neurons.
150. Synthesis and structure-activity relationships of N-(2-oxo-3-oxetanyl)amides as N-acylethanolamine-hydrolyzing acid amidase inhibitors.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.